Dr. Anuradha Kunthur, MD

Dr. Kunthur practices at UAMS Medical Center in Little Rock, Arkansas, part of University of Arkansas for Medical Sciences.

Dr. Kunthur's NPI, 1770526147, was assigned on June 14, 2006. Dr. Kunthur holds Arkansas license E-7727.

Dr. Kunthur's primary practice is UAMS Medical Center, at 4301 West Markham Street Mail Slot 612, Little Rock, AR 72205 in Pulaski County. The practice phone is (501) 686-5000.

Dr. Kunthur's primary practice is UAMS Medical Center in Little Rock, Arkansas, part of University of Arkansas for Medical Sciences. The medical group on file is UAMS - University of Arkansas for Medical Sciences. Dmand AI also links Dr. Kunthur to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kunthur practices. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Kunthur's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Kunthur is licensed in Arkansas.

CMS data shows 453 Medicare services from Dr. Kunthur across 12 procedure codes in 2024, for 166 Medicare patients. Medicare paid $30,682 for them.

CMS counts 166 Medicare patients who saw Dr. Kunthur in 2024. The largest group is 65 to 74, with 69 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 14% are also on Medicaid. Their average risk score is 2.37, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kunthur's median patient age at 69, with 32% women.

In 2024, Dr. Kunthur wrote 232 Medicare Part D claims for 66 patients. 73% of them were for generic drugs. CMS names the drug for 122 of them, across 7 drugs with 11 or more claims each, at $433,114 in total drug cost. In 2023, CMS named 109 claims across 6 drugs.

Dr. Kunthur accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kunthur as offering telehealth.

Dmand AI links 5 papers to Dr. Kunthur, published from 2015 to 2019. 2015 was the busiest year, with 2. Dr. Kunthur's most frequent co-authors are Sarah Witt Jewell, MD, Aasiya Matin, MD and Yadav Pandey, MD.

Dmand AI links Dr. Kunthur to 5 clinical trials, 3 of them phase 3 studies. 3 are still active or recruiting. Conditions studied include Prostatic Neoplasms, Prostatic Diseases and Carcinoma, Renal Cell. National Cancer Institute (NCI) sponsors the most, 3.

CMS Open Payments shows 213 general payments to Dr. Kunthur from 41 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 94% of the total. Novartis Pharmaceuticals Corporation paid the most, $593.